Clinical Trials Logo

Clinical Trial Summary

The high success rate of the non-penetrating deep sclerectomy (NPDS) procedure in adult glaucomatous patients motivated some glaucoma specialists to try it as an alternative procedure in childhood PCG. In deep sclerectomy, the surgeon fashions a partial-thickness scleral flap and excises the outer parts of both Schlemm's canal and trabecular meshwork without opening the eye, leaving a thin trabeculo-descemetic membrane. This membrane will guard against early postoperative hypotony due to the non-penetrating nature of the procedure. The aim of this study is to assess the safety and efficacy outcomes of non-penetrating deep sclerectomy versus combined trabeculotomy-trabeculectomy in the treatment of congenital primary glaucoma


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06189326
Study type Interventional
Source Al-Azhar University
Contact
Status Active, not recruiting
Phase N/A
Start date February 1, 2022
Completion date February 1, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02121171 - Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma Phase 1
Not yet recruiting NCT05115708 - Kahook Dual Blade Ab-interno Trabeculotomy Versus ab Externo Viscotrabeculotomy in Primary Congenital Glaucoma N/A
Unknown status NCT01460017 - Comparison Between Deep Sclerectomy and Traditional Trabeculotomy & Trabeculectomy in Congenital Glaucoma Phase 1
Recruiting NCT01136460 - Genetic Testing in Primary Congenital Glaucoma Patients N/A
Completed NCT02945176 - Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation N/A
Completed NCT05943184 - Cognitive Behavioral Nursing Model N/A
Active, not recruiting NCT03077789 - Prospective Study of the Diagnostic and Therapeutic Management of Congenital Glaucoma in France N/A